Cantor Fitzgerald analyst Joseph Foresi maintained a Buy rating on Exponent (EXPO) today and set a price target of $56. The company’s shares opened today at $51.40, close to its 52-week high of $54.58.
Foresi said:
“: We continue our bi-weekly Fundamentals and Charts series, in which we look at our coverage universe periodically for an opportunity in names where the Fundamentals match up with the Technicals. We look this week at Overweight-rated EXPO with a 12-month price target of $56. Fundamentally, we believe there is opportunity for upside, as many catalysts exist in a number of areas. We note Exponent has a defensive element to its business. Technically, EXPO trending sideways with the potential to break out to the upside. Click Here for our previous Fundamentals & Charts with EXPO in an uptrend.”
According to TipRanks.com, Foresi is a top 100 analyst with an average return of 15.7% and a 68.2% success rate. Foresi covers the Technology sector, focusing on stocks such as Jack Henry & Associates, Fidelity National Info, and DXC Technology Company.
Exponent has an analyst consensus of Moderate Buy, with a price target consensus of $56.
See today’s analyst top recommended stocks >>
Exponent’s market cap is currently $2.66B and has a P/E ratio of 52.88. The company has a Price to Book ratio of 8.04.
Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of solutions. It operates through two segments: Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment provides technical consulting in the areas of engineering and technology development.
